EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Impact of hematological markers in prediction of severity of cutaneous drug eruptions

Rezvan Amiri, Behzad Iranmanesh, Mina Amiri, Saman Mohammadi, Maryam Khalili, Mahin Aflatoonian

Journal of Pakistan Association of Dermatologists · 02.07.2023 · 33 (2) · 574-578

DOI: 10.66344/jpad.v33i2.2176 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Pakistan Association of Dermatologists, online erschienen am 02.07.2023. Verfasst von Rezvan Amiri und 5 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Recognition of parameters to predict severity of drug eruptions can be helpful in early intervention in severe cases. In this study, we evaluate the role of hematological factors including neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte (PLR) ratio in prediction of severity in cutaneous drug reactions.

Methods

This is a retrospective cross-sectional study on 46 hospitalized patients with drug eruptions and 46 healthy individuals as control group. NLR/PLR was compared between patients with drug eruptions and healthy control group by independent t test. Moreover, the values of these hematological markers were compared between serious and non-serious types of drug eruptions by independent t test.

Results

Serious drug eruptions constitute nearly one-fourth of total drug eruptions. The mean values of NLR in case and control groups were 3.91±2.87 and 2.30±1.62, respectively (P=0.001). The mean values of PLR in case and control groups were 155.35±90.60 and 125±45.64, respectively (P=0.045). Females with drug eruptions had significantly higher PLR compared to males (P=0.02). Furthermore, there was no significant correlation between NLR/PLR in serious and non-serious types of drug reactions.

Conclusion

NLR/PLR was significantly higher in patients with drug eruptions compared to control group. There was no significant correlation between NLR/PLR with either demographic features of patients or severity of drug eruption; except significantly higher PLR in female with drug eruptions compared to males.

Zitieren

APA

Amiri, R., Iranmanesh, B., Amiri, M., Mohammadi, S., Khalili, M., & Aflatoonian, M. (2023). Impact of hematological markers in prediction of severity of cutaneous drug eruptions. Journal of Pakistan Association of Dermatologists, 33(2), 574-578. https://doi.org/10.66344/jpad.v33i2.2176

Vancouver

Amiri R, Iranmanesh B, Amiri M, Mohammadi S, Khalili M, Aflatoonian M. Impact of hematological markers in prediction of severity of cutaneous drug eruptions. Journal of Pakistan Association of Dermatologists. 2023;33(2):574-578. doi:10.66344/jpad.v33i2.2176

BibTeX
@article{Amiri2023,
  author = {Amiri, Rezvan and Iranmanesh, Behzad and Amiri, Mina and Mohammadi, Saman and Khalili, Maryam and Aflatoonian, Mahin},
  title = {Impact of hematological markers in prediction of severity of cutaneous drug eruptions},
  journal = {Journal of Pakistan Association of Dermatologists},
  year = {2023},
  volume = {33},
  number = {2},
  pages = {574--578},
  doi = {10.66344/jpad.v33i2.2176}
}
Kostenlos starten →